rfhg_108888.1

Basic information about the TSS

---

TSS ID: rfhg_108888.1 TSS ID(Version3): hg_94028.1 hg_231235.1 Species: human Chr: chr8		Start: 96235528 End: 96235630 Strand: -
Source datasets	FANTOM5|EPD|DBTSS|DRA000914|ENCODE|RAMPAGE|PRJNA401781 |PRJNA615891|PRJNA548673|PRJDB5282|PRJNA597322|PRJNA4843412 |DRA013844
Protocol	CAGE|TSS_database|TSS-seq|RAMPAGE|oligo_capping|TIF-seq2 |SLIC_CAGE|C1CAGE|STRIPE-seq|NETCAGE|ReCappable-seq
TSS cluster detected*	17

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4122576,EH38E2649465)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000287022.10:0 ENST00000517603.5:0 ENST00000521036.5:0 ENST00000518876.1:0 ENST00000518406.5:0 ENST00000523920.1:0 ENST00000519322.1:0 AK307085:0 BC005230:0 AK295007:0 M22348:0 X13585:0 BC041005:0 M26700:0 CR542176:0 AK311756:0 CR542196:0 GeneID: 7381 HGNC/MGI_ID: HGNC:12582 UniProt_ID: B2R4A2 B7Z2R2 E5RIT7 P14927 Nearer transcript ids and distances: LF331966:468 MA567543:468 view more...

Gene_name: ubiquinol-cytochrome c reductase binding protein Gene_symbol: UQCRB Gene_synonyms: QCR7 QP-C UQCR6 Gene_source: HGNC:12582

TATA-Box annotation

---

Distance to TSS:	55
Nearest PromoterID:	NM_001199975
Entrez ID:	7381
Nearest Unigene:	Hs.131255
Nearest Refseq:	NM_006294
Nearest Ensembl:	ENSG00000156467
Gene Name:	ubiquinol-cytochrome c reductase binding protein
Gene Alias:	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC
Gene Type:	protein-coding
CpG%:	0.068627
GC%:	0.543689
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UQCRB p2@UQCRB
Sample		p1@UQCRB	p2@UQCRB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	64.48	20.06
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	57.46	17.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	61.54	17.17
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	57.59	17.26
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	58.72	20.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	60.66	19.96
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	106.76	25.27
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	73.88	26.40
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	60.27	14.96
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	39.99	14.49
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	37.19	10.11
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	37.00	13.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	175.22	6.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	200.87	6.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	265.66	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	152.65	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	172.98	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	172.10	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	148.22	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	276.06	8.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	195.67	6.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	261.87	9.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	192.21	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	198.99	6.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	218.52	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	296.89	5.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	246.16	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	256.03	7.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	214.02	7.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	214.63	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	183.39	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	211.01	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	186.55	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	323.45	11.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	220.27	8.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	163.65	4.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	224.21	8.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	176.91	6.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	255.25	9.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	236.70	9.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	175.27	5.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	248.14	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	210.05	7.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	207.69	7.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	298.15	9.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	311.05	12.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	165.78	7.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	352.89	14.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	196.77	7.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	236.98	11.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	243.08	12.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	204.58	9.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	2546.58	97.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	100.42	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	107.70	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	900.18	37.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	359.13	17.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	90.43	5.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	81.58	4.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	386.63	15.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	97.30	5.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	78.51	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	577.20	16.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	291.52	11.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	80.91	5.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	73.13	5.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1988.16	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	2353.45	102.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	62.40	4.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	80.33	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	52.07	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	113.27	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	61.25	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	51.67	3.97
Adipocyte - breast, donor1	11376-118A8	239.95	24.23
Adipocyte - breast, donor2	11327-117E4	185.77	28.40
Adipocyte - omental, donor1	11473-119C6	260.43	27.35
Adipocyte - omental, donor2	11474-119C7	90.45	20.93
Adipocyte - omental, donor3	11475-119C8	115.55	20.43
Adipocyte - perirenal, donor1	11476-119C9	82.30	12.76
Adipocyte - subcutaneous, donor1	11259-116F8	140.74	13.19
Adipocyte - subcutaneous, donor2	11336-117F4	97.10	14.00
Adipocyte - subcutaneous, donor3	11408-118E4	235.47	10.25
Adipocyte differentiation, day04, donor1	13019-139D4	277.13	14.08
Adipocyte differentiation, day04, donor2	13022-139D7	150.31	11.32
Adipocyte differentiation, day04, donor3	13025-139E1	120.43	11.99
Adipocyte differentiation, day04, donor4	13028-139E4	192.21	10.58
Adipocyte differentiation, day08, donor1	13020-139D5	486.38	60.65
Adipocyte differentiation, day08, donor2	13023-139D8	262.08	23.24
Adipocyte differentiation, day08, donor3	13026-139E2	272.46	18.66
Adipocyte differentiation, day08, donor4	13029-139E5	277.66	32.27
Adipocyte differentiation, day12, donor1	13021-139D6	256.19	46.16
Adipocyte differentiation, day12, donor2	13024-139D9	226.30	38.43
Adipocyte differentiation, day12, donor3	13027-139E3	272.92	38.29
Adipocyte differentiation, day12, donor4	13030-139E6	256.36	38.06
Alveolar Epithelial Cells, donor1	11510-119G7	139.89	15.91
Alveolar Epithelial Cells, donor2	11590-120G6	32.27	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	85.46	6.30
Amniotic Epithelial Cells, donor2	11613-122A2	95.39	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	137.86	9.25
Anulus Pulposus Cell, donor1	11248-116E6	384.36	27.92
Anulus Pulposus Cell, donor2	11463-119B5	106.29	10.53
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	217.91	19.32
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	209.26	20.40
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	237.57	23.54
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	219.41	26.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	240.28	20.23
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	172.94	20.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	165.69	17.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	183.01	18.45
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	207.26	31.48
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	218.07	28.25
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	161.10	19.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	194.34	22.57
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	239.69	24.55
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	102.36	24.57
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	208.69	30.46
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	157.52	24.65
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	205.00	25.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	181.49	25.12
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	104.37	12.68
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	213.79	22.06
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	213.73	26.42
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	99.12	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	178.91	18.18
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	213.94	25.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	192.23	16.99
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	235.64	28.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	204.72	24.23
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	207.49	18.24
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	175.30	20.52
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	168.02	14.97
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	174.54	13.14
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	175.89	20.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	187.64	15.70
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	135.12	14.04
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	166.19	21.38
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	177.01	22.57
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	272.08	22.89
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	273.79	30.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	185.53	19.70
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	167.87	15.10
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	213.80	18.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	164.42	18.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	150.21	21.73
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	195.46	17.80
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	178.36	16.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	73.94	8.45
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	182.04	18.01
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	217.20	21.66
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	199.01	24.06
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	225.05	25.29
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	181.07	22.95
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	246.10	31.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	178.78	18.37
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	193.09	21.42
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	220.36	20.08
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	171.41	21.07
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	215.14	21.36
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	172.81	17.17
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	174.76	18.01
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	181.36	16.72
Astrocyte - cerebellum, donor1	11500-119F6	84.87	14.00
Astrocyte - cerebellum, donor2	11580-120F5	43.65	5.82
Astrocyte - cerebellum, donor3	11661-122F5	101.10	4.40
Astrocyte - cerebral cortex, donor1	11235-116D2	349.98	23.36
Astrocyte - cerebral cortex, donor2	11316-117D2	151.26	19.25
Astrocyte - cerebral cortex, donor3	11392-118C6	164.23	13.87
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	210.56	33.37
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	208.59	36.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	201.42	37.89
Basophils, donor1	12241-129G9	217.07	12.29
Basophils, donor2	12242-129H1	469.03	22.37
Basophils, donor3	12243-129H2	252.25	8.53
Bronchial Epithelial Cell, donor1	11511-119G8	89.04	6.04
Bronchial Epithelial Cell, donor2	11591-120G7	10.97	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	164.99	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	99.17	31.38
Bronchial Epithelial Cell, donor5	11457-119A8	13.52	2.29
Bronchial Epithelial Cell, donor6	11461-119B3	49.51	5.07
Bronchial Epithelial Cell, donor7	11769-123I5	234.65	19.25
Burkitt's lymphoma cell line:DAUDI	10422-106C8	299.27	22.05
Burkitt's lymphoma cell line:RAJI	10476-106I8	721.30	55.66
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	584.23	29.10
CD133+ stem cells - cord blood derived, pool1	12223-129E9	455.05	41.37
CD14+ Monocytes, donor1	11224-116B9	367.44	10.71
CD14+ Monocytes, donor2	11305-117B9	189.13	7.05
CD14+ Monocytes, donor3	11381-118B4	142.26	7.90
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	392.58	33.12
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	384.76	23.88
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	401.39	26.30
CD14+ monocytes - mock treated, donor1	11863-125A9	248.77	12.14
CD14+ monocytes - mock treated, donor2	11873-125C1	204.28	7.24
CD14+ monocytes - mock treated, donor3	11883-125D2	174.12	9.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	170.41	10.04
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	147.11	4.42
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	162.64	11.65
CD14+ monocytes - treated with BCG, donor1	11860-125A6	165.06	8.62
CD14+ monocytes - treated with BCG, donor2	11870-125B7	197.63	5.52
CD14+ monocytes - treated with BCG, donor3	11880-125C8	272.47	14.36
CD14+ monocytes - treated with Candida, donor1	11868-125B5	181.45	4.92
CD14+ monocytes - treated with Candida, donor2	11878-125C6	238.14	8.98
CD14+ monocytes - treated with Candida, donor3	11888-125D7	218.54	6.66
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	192.48	9.97
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	186.98	6.78
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	326.46	19.36
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	215.06	11.21
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	235.48	9.95
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	137.49	5.67
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	181.03	9.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	221.39	10.47
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	158.65	8.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	177.65	8.82
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	145.13	5.64
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	137.76	5.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	163.74	9.24
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	173.57	7.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	360.83	15.30
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	153.56	5.32
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	216.50	8.81
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	253.57	12.99
CD14+CD16+ Monocytes, donor1	11789-124B7	439.42	35.53
CD14+CD16+ Monocytes, donor2	11801-124D1	492.71	38.11
CD14+CD16+ Monocytes, donor3	11912-125G4	420.02	38.12
CD14+CD16- Monocytes, donor1	11788-124B6	432.13	35.35
CD14+CD16- Monocytes, donor2	11799-124C8	336.02	23.05
CD14+CD16- Monocytes, donor3	11910-125G2	419.63	21.63
CD14-CD16+ Monocytes, donor1	11790-124B8	762.46	78.34
CD14-CD16+ Monocytes, donor2	11800-124C9	579.65	47.43
CD14-CD16+ Monocytes, donor3	11911-125G3	555.42	60.85
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	569.05	32.52
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	607.47	23.05
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	605.82	36.25
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	646.04	24.52
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	687.77	25.73
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	598.05	31.59
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	585.91	25.88
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	736.92	30.32
CD19+ B Cells, donor1	11544-120B5	168.49	7.40
CD19+ B Cells, donor2	11624-122B4	229.24	5.08
CD19+ B Cells, donor3	11705-123B4	210.51	7.07
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	516.39	101.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	436.24	112.26
CD34+ Progenitors, donor1	11545-120B6	465.88	16.06
CD34+ Progenitors, donor2	11625-122B5	329.78	12.92
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	442.64	25.55
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	617.82	39.23
CD4+ T Cells, donor1	11225-116C1	769.46	14.28
CD4+ T Cells, donor2	11306-117C1	352.72	12.25
CD4+ T Cells, donor3	11382-118B5	324.51	8.23
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	643.20	38.03
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	526.68	39.98
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	516.85	35.07
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	970.94	27.97
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1214.31	32.31
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	570.25	19.78
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	643.24	43.50
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	353.50	44.06
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	322.09	37.88
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	570.68	38.55
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	629.60	36.69
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	625.65	41.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	520.31	40.06
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	308.95	29.71
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	317.42	29.74
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	985.76	19.85
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1145.86	21.97
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	616.87	14.35
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	614.14	40.24
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	416.34	39.21
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	404.54	37.83
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	784.19	26.80
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	811.48	30.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	728.25	26.58
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	914.52	34.64
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	996.12	37.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1118.05	48.85
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	545.83	21.88
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	632.62	32.64
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	762.30	33.88
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	964.05	34.74
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1009.66	36.01
CD8+ T Cells, donor1	11226-116C2	542.82	13.42
CD8+ T Cells, donor2	11307-117C2	254.54	5.63
CD8+ T Cells, donor3	11383-118B6	443.37	11.61
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	68.59	8.72
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	58.23	8.87
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	74.69	9.85
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	91.26	10.51
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	70.31	9.12
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	61.17	11.37
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	61.06	13.04
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	68.96	10.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	71.06	14.54
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	87.24	20.53
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	83.96	22.37
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	65.28	11.99
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	45.53	6.13
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	47.36	10.02
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	37.29	7.46
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	54.02	7.56
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	72.51	9.21
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	66.00	8.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	73.52	10.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	60.90	13.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.54	8.34
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	56.60	13.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	49.66	9.46
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.17	13.62
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.05	11.24
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	83.23	13.99
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	82.14	9.02
Cardiac Myocyte, donor1	11525-119I4	153.53	14.62
Cardiac Myocyte, donor2	11605-120I3	178.37	16.80
Cardiac Myocyte, donor3	11686-122I3	219.30	10.31
Chondrocyte - de diff, donor1	11261-116G1	149.07	21.15
Chondrocyte - de diff, donor2	11338-117F6	142.51	8.17
Chondrocyte - de diff, donor3	11410-118E6	222.67	12.40
Chondrocyte - re diff, donor2	11339-117F7	100.27	9.85
Chondrocyte - re diff, donor3	11411-118E7	208.27	4.85
Ciliary Epithelial Cells, donor1	11242-116D9	354.95	27.31
Ciliary Epithelial Cells, donor2	11323-117D9	191.75	15.82
Ciliary Epithelial Cells, donor3	11399-118D4	178.23	15.31
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	160.66	21.92
Corneal Epithelial Cells, donor1	11526-119I5	59.72	3.51
Corneal Epithelial Cells, donor2	11606-120I4	59.16	9.10
Corneal Epithelial Cells, donor3	11687-122I4	81.80	7.16
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	265.80	34.01
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	261.79	47.31
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	234.65	37.96
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	157.02	24.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	363.51	10.93
Dendritic Cells - plasmacytoid, donor2	11309-117C4	527.52	22.85
Dendritic Cells - plasmacytoid, donor3	11385-118B8	274.40	18.39
Endothelial Cells - Aortic, donor0	11207-116A1	60.87	6.50
Endothelial Cells - Aortic, donor1	11263-116G3	94.47	8.80
Endothelial Cells - Aortic, donor2	11340-117F8	98.70	7.07
Endothelial Cells - Aortic, donor3	11412-118E8	56.62	5.50
Endothelial Cells - Artery, donor1	11264-116G4	126.24	13.67
Endothelial Cells - Artery, donor2	11341-117F9	108.70	13.65
Endothelial Cells - Artery, donor3	11413-118E9	111.85	14.02
Endothelial Cells - Lymphatic, donor1	11236-116D3	260.88	22.61
Endothelial Cells - Lymphatic, donor2	11317-117D3	221.20	11.56
Endothelial Cells - Lymphatic, donor3	11393-118C7	204.38	7.33
Endothelial Cells - Microvascular, donor1	11265-116G5	162.23	14.56
Endothelial Cells - Microvascular, donor2	11342-117G1	144.74	19.79
Endothelial Cells - Microvascular, donor3	11414-118F1	139.09	6.10
Endothelial Cells - Thoracic, donor1	11266-116G6	198.06	27.21
Endothelial Cells - Thoracic, donor2	11343-117G2	97.49	12.58
Endothelial Cells - Umbilical vein, donor1	11243-116E1	401.69	36.65
Endothelial Cells - Umbilical vein, donor2	11324-117E1	194.88	19.99
Endothelial Cells - Umbilical vein, donor3	11400-118D5	177.57	19.05
Endothelial Cells - Vein, donor1	11267-116G7	40.95	13.65
Endothelial Cells - Vein, donor2	11344-117G3	37.72	6.29
Endothelial Cells - Vein, donor3	11416-118F3	82.74	8.95
Eosinophils, donor1	12244-129H3	365.93	15.25
Eosinophils, donor2	12245-129H4	171.63	24.75
Eosinophils, donor3	12246-129H5	128.41	14.27
Esophageal Epithelial Cells, donor1	11507-119G4	80.63	6.84
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	242.61	14.78
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	82.01	10.73
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	117.22	9.97
Fibroblast - Aortic Adventitial, donor1	11245-116E3	278.46	25.59
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	91.57	15.28
Fibroblast - Aortic Adventitial, donor2	11326-117E3	169.17	14.55
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	28.46	6.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	180.38	21.26
Fibroblast - Cardiac, donor1	11268-116G8	142.44	11.79
Fibroblast - Cardiac, donor2	11345-117G4	38.66	6.06
Fibroblast - Cardiac, donor3	11417-118F4	103.46	8.83
Fibroblast - Cardiac, donor4	11452-119A3	266.43	10.91
Fibroblast - Cardiac, donor5	11456-119A7	104.32	10.53
Fibroblast - Cardiac, donor6	11460-119B2	120.52	17.89
Fibroblast - Choroid Plexus, donor1	11492-119E7	88.30	5.09
Fibroblast - Choroid Plexus, donor2	11572-120E6	187.24	10.79
Fibroblast - Choroid Plexus, donor3	11653-122E6	175.78	16.11
Fibroblast - Conjunctival, donor1	11531-120A1	92.72	6.23
Fibroblast - Conjunctival, donor3	11692-122I9	420.28	10.18
Fibroblast - Dermal, donor1	11269-116G9	200.97	21.13
Fibroblast - Dermal, donor2	11346-117G5	83.49	14.15
Fibroblast - Dermal, donor3	11418-118F5	186.16	15.84
Fibroblast - Dermal, donor4	11450-119A1	121.86	20.91
Fibroblast - Dermal, donor5	11454-119A5	109.38	20.93
Fibroblast - Dermal, donor6	11458-119A9	136.92	29.24
Fibroblast - Gingival, donor1	11237-116D4	332.75	31.44
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	215.89	14.93
Fibroblast - Gingival, donor2	11318-117D4	246.57	28.99
Fibroblast - Gingival, donor3	11394-118C8	218.03	10.25
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	234.79	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	123.52	8.46
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	237.74	23.85
Fibroblast - Gingival, donor6 (control)	11922-125H5	171.06	21.77
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	243.20	21.50
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	248.84	30.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	207.21	21.17
Fibroblast - Gingival, donor9 (control)	11927-125I1	269.41	7.63
Fibroblast - Lung, donor1	11270-116H1	31.27	8.16
Fibroblast - Lung, donor2	11347-117G6	217.85	20.89
Fibroblast - Lung, donor3	11419-118F6	100.88	14.56
Fibroblast - Lymphatic, donor1	11506-119G3	64.14	10.83
Fibroblast - Lymphatic, donor2	11586-120G2	37.76	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	74.17	4.20
Fibroblast - Mammary, donor1	11540-120B1	190.81	11.77
Fibroblast - Mammary, donor2	11620-122A9	47.93	11.98
Fibroblast - Mammary, donor3	11701-123A9	184.64	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	350.70	39.57
Fibroblast - Periodontal Ligament, donor2	11319-117D5	191.27	21.99
Fibroblast - Periodontal Ligament, donor3	11395-118C9	200.12	18.36
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	165.62	17.17
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	203.57	22.41
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	124.32	7.07
Fibroblast - Pulmonary Artery, donor1	11250-116E8	261.30	41.23
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	97.73	8.53
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	102.24	8.02
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	214.68	16.21
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.91	10.12
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	294.14	9.59
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	284.20	13.01
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	36.70	9.03
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	193.88	18.89
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	44.03	6.83
Fibroblast - skin normal, donor1	11553-120C5	196.40	15.92
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.21	13.43
Fibroblast - skin normal, donor2	11561-120D4	147.48	16.17
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	51.98	11.79
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	345.55	10.94
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	211.12	12.48
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	35.47	8.87
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	163.30	26.74
Fibroblast - skin walker warburg, donor1	11554-120C6	94.80	14.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	306.58	23.21
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2548.38	288.08
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	142.93	26.15
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	186.36	29.12
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	201.95	27.85
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	175.79	23.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	181.44	19.90
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	260.33	30.63
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	720.01	77.02
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	476.51	24.82
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	205.95	16.67
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	374.27	37.05
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	394.92	27.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	148.72	14.02
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	551.90	68.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	229.08	22.47
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	166.24	16.87
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	179.17	18.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	167.01	14.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	157.25	15.78
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	189.88	22.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	202.39	16.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	144.25	11.96
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	138.14	9.40
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	250.57	16.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	171.52	13.67
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	163.99	15.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	174.61	13.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	192.37	19.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	209.53	21.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	256.91	9.26
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	251.72	9.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	198.62	15.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	236.19	19.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	223.99	14.70
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	263.45	16.30
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	179.51	10.95
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	165.93	13.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	203.24	9.26
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	299.98	16.73
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	178.30	14.91
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	272.61	15.07
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	141.75	8.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	165.61	12.97
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	215.90	18.55
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	147.50	14.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	196.72	10.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	170.85	13.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	124.53	14.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	194.14	28.08
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	151.17	17.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	139.51	15.16
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	200.59	14.64
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	197.62	16.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	227.43	14.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	239.01	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	165.02	13.59
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	154.14	13.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	222.14	5.34
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	211.60	29.86
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	227.88	21.11
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	254.71	27.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	270.68	29.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	288.49	38.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	208.00	30.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	381.12	34.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	312.93	38.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	343.36	28.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	276.47	29.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	316.37	37.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	364.44	43.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	233.26	26.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	311.25	31.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	276.18	29.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	269.27	16.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	311.71	26.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	298.56	29.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	622.27	29.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	339.61	22.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	198.60	15.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	452.34	42.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	354.56	38.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	273.85	27.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	458.36	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	280.62	21.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	315.54	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	460.16	26.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	430.34	24.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	325.91	20.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	402.54	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	466.19	14.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	356.06	18.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	492.91	15.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	422.77	24.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	487.93	20.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	496.97	27.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	453.92	26.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	388.85	16.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	322.12	15.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	318.16	26.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	288.24	25.23
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	69.62	12.55
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	107.28	10.40
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	53.97	11.24
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	247.70	13.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	253.15	23.39
Hep-2 cells mock treated, biol_rep1	11898-125E8	346.39	94.57
Hep-2 cells mock treated, biol_rep2	11899-125E9	259.11	76.47
Hep-2 cells mock treated, biol_rep3	11900-125F1	248.89	64.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	327.71	97.39
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	269.28	74.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	234.66	65.88
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	357.17	88.30
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	300.90	83.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	293.46	71.44
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	50.93	9.51
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	107.33	11.25
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	216.79	15.86
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	114.99	12.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	73.38	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	157.18	28.50
Hepatocyte, donor1	11523-119I2	184.01	42.37
Hepatocyte, donor2	11603-120I1	148.67	42.02
Hepatocyte, donor3	11684-122I1	165.66	25.77
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	331.56	51.56
Intestinal epithelial cells (polarized), donor1	11246-116E4	301.50	36.18
Iris Pigment Epithelial Cells, donor1	11530-119I9	246.56	24.29
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	8.31
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	51.00	6.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	70.54	8.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	36.18	7.11
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	14.49	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.65	5.88
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.88	16.07
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	55.40	6.46
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	45.79	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	40.81	15.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	37.66	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	10.16
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	31.25	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	35.70	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	87.04	17.59
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.86	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	32.00	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	2.11
Keratinocyte - epidermal, donor1	11272-116H3	129.17	12.16
Keratinocyte - epidermal, donor2	11349-117G8	30.45	5.86
Keratinocyte - epidermal, donor3	11421-118F8	180.60	16.56
Keratinocyte - oral, donor1	11251-116E9	365.19	19.64
Keratocytes, donor1	11527-119I6	112.09	6.19
Keratocytes, donor2	11607-120I5	70.31	16.41
Keratocytes, donor3	11688-122I5	156.30	10.08
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	21.98
Lens Epithelial Cells, donor1	11529-119I8	152.10	18.34
Lens Epithelial Cells, donor2	11609-120I7	364.56	15.80
Lens Epithelial Cells, donor3	11690-122I7	210.60	12.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	181.30	9.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	113.58	9.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	242.41	17.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	123.14	11.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	96.13	6.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	136.39	7.33
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	118.19	8.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	73.82	5.06
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	136.11	9.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	158.61	11.87
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	166.74	10.66
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	62.77	4.63
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	142.85	8.71
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	104.71	5.25
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	116.20	10.58
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	141.35	12.01
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	74.51	5.61
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	114.37	9.15
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	135.59	7.90
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	87.57	4.98
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	78.66	6.22
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	171.19	14.06
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	157.81	12.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	137.15	11.50
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	135.31	12.96
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	166.88	11.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	124.06	8.12
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	154.77	11.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	148.45	8.09
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	88.64	7.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	127.44	7.75
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	103.87	6.62
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	92.79	5.45
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	188.81	15.18
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	135.40	11.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	86.48	5.36
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	147.31	12.54
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	170.42	12.17
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	220.03	14.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	159.29	16.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	81.44	7.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	68.93	5.91
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	122.11	10.03
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	99.96	7.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	73.92	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	144.79	8.66
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	75.81	4.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	122.62	5.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	61.18	15.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	82.85	15.34
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	78.68	14.10
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	65.16	13.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	79.48	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	74.72	11.21
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	69.56	14.94
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	64.23	14.27
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	86.18	15.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	144.54	30.54
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	190.87	27.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	88.34	15.85
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	61.62	17.97
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	135.50	21.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	162.58	23.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	88.63	14.26
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	170.76	25.61
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	183.09	33.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	62.58	11.66
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	90.51	17.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	189.08	36.23
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	150.78	27.19
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	64.91	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	156.47	31.93
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	121.07	23.91
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	156.57	26.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	71.05	13.08
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	82.61	16.23
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	80.59	11.51
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	71.76	13.43
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	62.27	12.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	109.94	15.59
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	57.39	11.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	60.32	22.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	144.90	10.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	64.66	15.24
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	105.96	21.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	112.17	23.98
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	101.95	21.32
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.69	14.48
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.15	9.95
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	82.15	18.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	52.60	17.18
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	74.74	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	74.82	20.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	76.75	15.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	46.54	11.64
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	72.43	12.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	42.16	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	66.69	10.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	77.44	14.31
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	9.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	51.79	12.57
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	58.58	12.17
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	63.68	8.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	86.40	20.93
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	60.22	12.12
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	15.83
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	68.50	8.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	66.07	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	73.80	17.33
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	69.78	9.72
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	86.40	19.67
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	52.66	16.20
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	85.07	12.02
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	76.73	16.30
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.08	13.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	36.66	17.29
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	76.00	11.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	51.64	10.33
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	25.40	7.86
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	77.01	11.09
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	50.64	10.66
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	22.41	6.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	57.08	13.88
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	44.56	12.73
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	9.08
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.84	7.90
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	56.38	8.61
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	27.98	5.43
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	62.26	11.15
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	53.52	13.38
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.22	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	70.72	12.53
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	50.48	11.01
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	18.67	11.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	82.06	10.26
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	5.37
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	46.51	18.06
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	62.36	8.91
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	56.41	17.68
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.79	12.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	4.16
Macrophage - monocyte derived, donor1	11232-116C8	233.61	33.05
Macrophage - monocyte derived, donor2	11313-117C8	238.56	45.88
Macrophage - monocyte derived, donor3	11389-118C3	149.43	27.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	213.47	57.35
Mallassez-derived cells, donor2	11929-125I3	250.51	38.66
Mallassez-derived cells, donor3	11930-125I4	295.63	44.48
Mammary Epithelial Cell, donor1	11273-116H4	322.15	23.12
Mammary Epithelial Cell, donor2	11350-117G9	191.97	20.56
Mammary Epithelial Cell, donor3	11422-118F9	44.65	5.24
Mast cell - stimulated, donor1	11487-119E2	558.62	20.34
Mast cell, donor1	11563-120D6	359.78	15.90
Mast cell, donor2	11565-120D8	255.27	10.40
Mast cell, donor3	11566-120D9	240.66	12.83
Mast cell, donor4	11567-120E1	206.72	6.74
Mast cell, expanded and stimulated, donor5	11940-126A5	306.95	38.15
Mast cell, expanded and stimulated, donor8	11942-126A7	199.04	16.34
Mast cell, expanded, donor5	11939-126A4	216.94	29.60
Mast cell, expanded, donor8	11941-126A6	255.57	14.06
Melanocyte - dark, donor1	11502-119F8	409.33	26.07
Melanocyte - dark, donor2	11582-120F7	194.84	22.50
Melanocyte - dark, donor3	11663-122F7	203.70	24.48
Melanocyte - light, donor1	11274-116H5	37.85	2.82
Melanocyte - light, donor2	11351-117H1	21.84	3.41
Melanocyte - light, donor3	11423-118G1	43.36	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	163.27	21.45
Melanocyte, donor2 (MC+2)	12739-135I3	132.59	14.79
Melanocyte, donor3 (MC+3)	12837-137B2	198.48	13.12
Meningeal Cells, donor1	11493-119E8	103.47	11.54
Meningeal Cells, donor2	11573-120E7	57.66	11.00
Meningeal Cells, donor3	11654-122E7	267.16	31.30
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	377.55	49.90
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	252.18	17.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	86.73	6.57
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	56.25	6.54
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	162.90	24.40
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	216.64	17.36
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	150.29	11.56
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	98.89	13.84
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	108.13	11.69
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	72.43	10.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	207.35	12.19
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	92.93	2.97
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	310.25	13.16
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	149.85	5.04
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	138.33	12.17
Mesenchymal stem cells - adipose, donor0	11217-116B2	260.87	40.76
Mesenchymal stem cells - hepatic, donor0	11218-116B3	294.90	13.45
Mesenchymal stem cells - umbilical, donor0	11214-116A8	158.20	26.85
Mesothelial Cells, donor1	11247-116E5	251.92	29.70
Mesothelial Cells, donor2	12156-128G5	159.15	14.01
Mesothelial Cells, donor3	11402-118D7	153.06	13.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	144.48	20.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	280.51	44.82
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	200.53	36.22
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	260.05	40.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	196.44	34.43
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	217.23	35.54
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	174.55	19.08
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	206.26	31.09
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	139.77	27.32
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	151.32	25.66
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	212.00	36.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	43.42	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	179.33	32.05
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	85.64	9.21
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	101.34	14.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	57.01	6.71
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	173.12	27.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	137.37	25.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	56.95	5.53
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	195.48	32.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	158.18	27.13
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	136.97	18.34
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	213.68	31.11
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	140.49	20.01
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	124.62	19.27
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	103.42	12.17
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	33.14	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	128.56	20.11
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	126.16	18.23
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	32.71	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	138.40	24.03
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	139.28	23.61
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	57.59	8.23
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	108.63	19.52
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	242.52	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	59.12	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	137.95	21.02
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	34.21	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	53.15	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	158.42	26.53
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	66.81	11.13
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	163.07	25.64
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	60.83	7.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	59.30	7.46
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	115.87	25.81
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	67.75	8.73
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	33.80	4.66
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	53.09	10.56
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	122.30	22.96
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	69.27	15.70
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	95.61	19.92
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	72.13	9.12
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	85.78	13.48
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	93.95	14.16
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	53.38	7.21
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	142.48	25.44
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	54.52	7.20
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	94.28	12.74
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	128.70	23.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	39.06	7.96
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	101.71	21.59
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	143.80	26.79
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	54.74	4.56
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	94.97	14.11
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	139.84	34.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	138.89	16.90
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	78.32	14.29
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	195.88	26.37
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	231.69	19.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	216.53	20.70
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	211.44	35.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	218.84	23.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	221.65	13.97
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	256.86	19.90
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	178.45	25.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	199.28	30.65
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	126.72	10.31
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	141.44	13.19
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	191.34	32.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	307.84	51.84
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	115.92	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	82.82	9.09
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	197.33	29.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	503.92	51.75
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	462.86	45.14
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	495.62	75.31
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	359.48	63.44
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	171.31	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	698.16	55.46
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	175.84	19.01
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	208.76	22.62
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	221.06	12.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	33.37	4.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.20	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	208.78	17.11
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	306.40	23.94
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	847.15	82.69
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	27.62	5.02
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	54.62	6.74
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	40.80	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	130.98	9.46
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1748.15	89.08
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	64.03	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	135.33	5.95
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	54.18	4.76
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	47.68	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	206.49	9.66
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	71.61	5.83
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.82	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	582.84	15.42
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	41.14	1.63
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	254.52	7.58
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	65.40	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	53.33	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	61.06	3.53
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	520.78	20.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1567.64	30.34
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	167.09	6.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	58.85	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	90.91	2.85
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	57.52	3.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2184.72	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	50.32	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	103.70	4.51
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	46.03	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	61.29	4.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	108.59	4.92
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	34.87	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.99	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	206.24	11.31
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.98	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.85	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	45.64	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	25.65	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	96.18	4.54
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	158.03	9.06
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.76	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1824.10	56.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	46.95	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	32.73	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	41.16	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	51.42	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	496.54	21.54
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	2093.97	116.33
Myoblast, donor1	11241-116D8	228.83	40.25
Myoblast, donor2	11322-117D8	194.47	25.51
Myoblast, donor3	11398-118D3	222.82	23.37
NK T cell leukemia cell line:KHYG-1	10777-110G3	242.98	13.13
Natural Killer Cells, donor1	11230-116C6	484.03	14.15
Natural Killer Cells, donor2	11311-117C6	268.69	8.14
Natural Killer Cells, donor3	11387-118C1	222.89	9.20
Neural stem cells, donor1	11275-116H6	252.24	21.41
Neural stem cells, donor2	11352-117H2	206.04	21.18
Neurons, donor1	11494-119E9	196.86	25.03
Neurons, donor2	11574-120E8	165.56	24.22
Neurons, donor3	11655-122E8	193.21	28.78
Neutrophils, donor1	11233-116C9	146.62	23.20
Neutrophils, donor2	11314-117C9	84.07	17.39
Neutrophils, donor3	11390-118C4	125.22	25.66
Nucleus Pulposus Cell, donor1	11252-116F1	452.38	11.87
Nucleus Pulposus Cell, donor2	11409-118E5	202.53	8.47
Nucleus Pulposus Cell, donor3	11462-119B4	116.32	7.62
Olfactory epithelial cells, donor1	11933-125I7	148.80	9.36
Olfactory epithelial cells, donor2	11934-125I8	220.30	19.40
Olfactory epithelial cells, donor3	11935-125I9	171.96	15.10
Olfactory epithelial cells, donor4	11936-126A1	189.34	8.18
Oligodendrocyte - precursors, donor1	11496-119F2	231.10	22.87
Osteoblast - differentiated, donor1	11276-116H7	104.65	4.04
Osteoblast - differentiated, donor2	11353-117H3	57.16	2.29
Osteoblast - differentiated, donor3	11425-118G3	123.52	4.97
Osteoblast, donor1	11277-116H8	55.70	7.62
Osteoblast, donor2	11354-117H4	212.80	28.80
Osteoblast, donor3	11426-118G4	72.87	8.18
Pancreatic stromal cells, donor1	11249-116E7	298.45	27.21
Pericytes, donor1	11491-119E6	91.57	4.90
Pericytes, donor2	11571-120E5	86.47	6.34
Pericytes, donor3	11652-122E5	157.47	11.60
Perineurial Cells, donor1	11499-119F5	315.22	18.87
Perineurial Cells, donor2	11579-120F4	272.81	20.43
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	480.98	17.21
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	216.21	11.02
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	177.17	6.34
Placental Epithelial Cells, donor1	11278-116H9	165.74	20.57
Placental Epithelial Cells, donor2	11355-117H5	90.93	8.87
Placental Epithelial Cells, donor3	11427-118G5	84.42	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	71.20	9.81
Preadipocyte - breast, donor1	11467-119B9	188.34	15.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	58.22	7.44
Preadipocyte - breast, donor2	11328-117E5	139.82	11.93
Preadipocyte - omental, donor1	11468-119C1	215.89	18.01
Preadipocyte - omental, donor2	11329-117E6	160.62	17.90
Preadipocyte - omental, donor3	11403-118D8	147.69	15.04
Preadipocyte - perirenal, donor1	11469-119C2	39.37	7.87
Preadipocyte - subcutaneous, donor1	11279-116I1	29.18	7.37
Preadipocyte - subcutaneous, donor2	11356-117H6	179.38	27.45
Preadipocyte - subcutaneous, donor3	11428-118G6	227.67	20.43
Preadipocyte - visceral, donor1	11280-116I2	365.42	38.94
Preadipocyte - visceral, donor2	11357-117H7	175.33	37.27
Preadipocyte - visceral, donor3	11429-118G7	126.43	23.61
Prostate Epithelial Cells (polarized), donor1	11253-116F2	219.34	28.51
Prostate Epithelial Cells, donor2	11331-117E8	94.92	16.79
Prostate Epithelial Cells, donor3	11404-118D9	154.69	10.78
Prostate Stromal Cells, donor1	11254-116F3	239.19	32.46
Prostate Stromal Cells, donor2	11332-117E9	183.78	22.77
Prostate Stromal Cells, donor3	11405-118E1	300.84	24.19
Renal Cortical Epithelial Cells, donor1	11516-119H4	73.36	4.74
Renal Cortical Epithelial Cells, donor2	11596-120H3	180.97	13.93
Renal Epithelial Cells, donor1	11517-119H5	71.01	6.59
Renal Epithelial Cells, donor2	11597-120H4	56.19	7.11
Renal Epithelial Cells, donor3	11678-122H4	234.81	17.26
Renal Glomerular Endothelial Cells, donor1	11514-119H2	24.51	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	52.69	10.51
Renal Glomerular Endothelial Cells, donor3	11675-122H1	164.73	22.87
Renal Glomerular Endothelial Cells, donor4	11783-124B1	47.91	2.00
Renal Mesangial Cells, donor1	11518-119H6	97.50	7.70
Renal Mesangial Cells, donor2	11598-120H5	79.00	9.40
Renal Mesangial Cells, donor3	11679-122H5	54.37	2.50
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	99.05	9.13
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	67.47	7.17
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	78.10	5.21
Retinal Pigment Epithelial Cells, donor0	11215-116A9	334.21	32.93
Retinal Pigment Epithelial Cells, donor1	11528-119I7	137.57	7.67
Retinal Pigment Epithelial Cells, donor2	11608-120I6	72.04	7.20
Retinal Pigment Epithelial Cells, donor3	11689-122I6	227.07	9.79
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	323.00	35.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	136.69	13.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	424.34	42.38
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	282.49	28.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	110.00	30.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	129.10	26.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	204.23	44.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	220.05	54.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	145.33	34.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	229.74	51.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	68.73	25.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	175.93	32.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	161.27	43.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	64.70	24.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	143.91	29.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	207.11	44.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	48.94	20.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	129.12	30.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	204.07	41.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	68.21	24.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	130.14	26.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	193.06	39.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	70.70	23.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	145.20	28.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	153.30	29.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	64.73	25.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	126.92	24.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	151.92	33.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	63.69	35.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	133.53	27.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	203.45	42.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	64.28	25.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	123.66	34.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	133.48	29.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	67.29	22.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	134.87	25.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	166.38	30.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	64.30	29.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	121.26	27.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	199.63	49.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	64.08	23.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	130.20	27.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	163.93	38.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	67.06	14.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	111.43	19.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	194.69	27.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	68.28	17.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	190.40	18.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	139.92	16.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	67.56	20.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	402.89	48.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	197.74	31.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	71.13	23.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	81.43	10.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	138.39	17.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.57	9.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	82.82	11.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	204.93	32.45
Schwann Cells, donor1	11498-119F4	39.49	6.39
Schwann Cells, donor2	11578-120F3	139.50	6.80
Schwann Cells, donor3	11659-122F3	130.79	20.81
Sebocyte, donor1	11220-116B5	157.21	2.19
Sebocyte, donor2	11301-117B5	141.08	10.11
Sebocyte, donor3	11378-118B1	132.32	7.63
Sertoli Cells, donor1	11255-116F4	268.37	13.25
Sertoli Cells, donor2	11333-117F1	177.94	8.47
Skeletal Muscle Cells, donor1	11281-116I3	195.57	7.39
Skeletal Muscle Cells, donor2	11358-117H8	34.70	0.72
Skeletal Muscle Cells, donor3	11430-118G8	24.25	5.02
Skeletal Muscle Cells, donor4	11451-119A2	178.14	37.39
Skeletal Muscle Cells, donor5	11455-119A6	145.52	27.35
Skeletal Muscle Cells, donor6	11459-119B1	138.67	25.55
Skeletal Muscle Satellite Cells, donor1	11240-116D7	464.71	36.79
Skeletal Muscle Satellite Cells, donor2	11321-117D7	211.18	18.26
Skeletal Muscle Satellite Cells, donor3	11397-118D2	175.01	22.22
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	253.43	12.22
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	40.53	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.45	4.40
Skin - palm, donor1	10286-104F7	142.36	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	51.32	6.49
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	32.72	12.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	46.09	5.97
Small Airway Epithelial Cells, donor1	11256-116F5	212.82	21.69
Small Airway Epithelial Cells, donor2	11334-117F2	126.31	7.88
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	100.01	14.80
Small Airway Epithelial Cells, donor3	11406-118E2	76.00	5.25
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	124.67	15.43
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	33.35	6.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	110.51	15.87
Smooth Muscle Cells - Aortic, donor1	11283-116I5	72.49	6.63
Smooth Muscle Cells - Aortic, donor2	11360-117I1	49.62	9.84
Smooth Muscle Cells - Aortic, donor3	11432-118H1	95.80	12.36
Smooth Muscle Cells - Bladder, donor1	11519-119H7	345.26	9.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	110.32	6.25
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	273.30	20.61
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	89.11	13.96
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	303.78	31.26
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	279.67	20.08
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	133.96	13.38
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	117.78	7.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	147.95	9.13
Smooth Muscle Cells - Carotid, donor1	11285-116I7	85.87	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	275.48	30.08
Smooth Muscle Cells - Colonic, donor2	11320-117D6	223.85	18.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	199.63	22.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	54.60	8.20
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	157.37	29.10
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	65.45	15.84
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	80.91	7.51
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	367.28	15.78
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	308.87	25.16
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	138.35	15.02
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.13	7.85
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	305.46	49.01
Smooth Muscle Cells - Prostate, donor1	11257-116F6	152.87	26.37
Smooth Muscle Cells - Prostate, donor2	11335-117F3	240.80	25.67
Smooth Muscle Cells - Prostate, donor3	11465-119B7	271.42	10.15
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	165.25	15.98
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	63.01	4.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	32.31	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	67.90	13.95
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	108.55	15.65
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	40.11	6.89
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	107.67	13.57
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	209.27	26.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	203.68	10.74
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	109.95	13.67
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	93.31	9.94
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	50.96	6.02
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	332.03	32.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	264.60	15.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	41.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	97.86	12.23
Smooth Muscle Cells - Uterine, donor1	11258-116F7	166.59	18.56
Smooth Muscle Cells - Uterine, donor3	11466-119B8	238.16	34.82
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	272.49	14.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	181.68	21.16
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	619.29	46.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	236.44	20.84
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	134.28	21.29
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	243.02	36.63
Smooth muscle cells - airway, control, donor1	11966-126D4	344.61	18.03
Smooth muscle cells - airway, control, donor2	11967-126D5	296.29	8.79
Smooth muscle cells - airway, control, donor3	11968-126D6	268.78	18.39
Smooth muscle cells - airway, control, donor4	11969-126D7	267.68	18.79
Synoviocyte, donor1	11291-117A4	313.75	21.38
Synoviocyte, donor2	11368-117I9	208.36	8.72
Synoviocyte, donor3	11440-118H9	111.03	10.05
Trabecular Meshwork Cells, donor1	11532-120A2	104.34	10.72
Trabecular Meshwork Cells, donor2	11612-122A1	55.50	9.91
Trabecular Meshwork Cells, donor3	11693-123A1	68.54	6.48
Tracheal Epithelial Cells, donor1	11292-117A5	220.86	16.27
Tracheal Epithelial Cells, donor2	11369-118A1	47.55	1.93
Tracheal Epithelial Cells, donor3	11441-118I1	24.05	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	323.18	30.14
Urethra, donor2	10319-105A4	206.82	12.59
Urothelial Cells, donor1	11520-119H8	105.73	8.77
Urothelial Cells, donor2	11600-120H7	64.09	9.21
Urothelial Cells, donor3	11681-122H7	52.72	3.44
Urothelial cells, donor0	11216-116B1	263.02	14.49
Whole blood (ribopure), donor090309, donation1	12179-129A1	274.05	20.47
Whole blood (ribopure), donor090309, donation2	12180-129A2	321.66	31.45
Whole blood (ribopure), donor090309, donation3	12181-129A3	240.27	14.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	419.75	18.59
Whole blood (ribopure), donor090325, donation2	12177-128I8	404.40	27.89
Whole blood (ribopure), donor090612, donation1	12182-129A4	160.35	18.74
Whole blood (ribopure), donor090612, donation2	12183-129A5	248.72	22.03
Whole blood (ribopure), donor090612, donation3	12184-129A6	251.05	17.35
Wilms' tumor cell line:G-401	10809-111A8	253.51	19.49
Wilms' tumor cell line:HFWT	10597-108E3	199.77	14.96
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	183.79	26.81
achilles tendon, donor2	10292-104G4	157.06	12.40
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	646.57	70.88
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	424.65	34.59
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	437.08	35.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	300.69	32.38
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	860.40	78.98
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	344.50	21.78
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	228.11	20.42
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	443.28	30.84
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	311.17	20.42
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	585.55	55.14
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	162.29	18.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	265.24	27.30
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	476.85	34.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	602.98	72.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	474.60	42.38
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	271.42	23.24
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	253.74	31.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	48.50	7.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	628.54	102.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	641.77	103.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	645.57	115.78
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	367.52	66.38
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	196.79	23.35
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	594.63	27.87
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	583.82	73.83
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	181.00	7.41
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	271.80	15.00
adenocarcinoma cell line:IM95m	10796-110I4	470.53	57.46
adipose tissue, adult, pool1	10010-101C1	206.15	12.56
adipose, donor1	10184-103D4	1685.34	77.99
adipose, donor2	10185-103D5	154.91	6.08
adipose, donor3	10186-103D6	208.57	16.34
adipose, donor4	10187-103D7	340.63	30.34
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	308.70	21.94
adrenal gland, adult, pool1	10081-102A9	98.22	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	283.89	25.88
alveolar cell carcinoma cell line:SW 1573	10708-109H6	384.81	60.74
amniotic membrane cells, donor1	12235-129G3	181.07	15.77
amniotic membrane cells, donor2	12236-129G4	289.75	12.51
amniotic membrane cells, donor3	12237-129G5	228.61	18.27
amygdala - adult, donor10196	10167-103B5	326.09	48.62
amygdala, adult, donor10252	10151-102I7	333.76	39.95
amygdala, newborn, donor10223	10360-105E9	199.79	27.76
anaplastic carcinoma cell line:8305C	10428-106D5	380.21	17.70
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	332.70	39.49
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	425.23	23.38
aorta, adult, pool1	10052-101G7	174.75	9.41
appendix, adult	10189-103D9	318.26	17.47
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	538.95	66.04
artery, adult	10190-103E1	817.93	101.90
astrocytoma cell line:TM-31	10425-106D2	313.20	14.20
b cell line:RPMI1788	10427-106D4	352.72	12.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	186.44	24.42
bile duct carcinoma cell line:HuCCT1	10432-106D9	282.21	26.99
bile duct carcinoma cell line:TFK-1	10496-107C1	261.28	47.37
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	359.59	17.90
bladder, adult, pool1	10011-101C2	418.81	17.27
blood, adult, pool1	10053-101G8	186.03	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	171.27	21.41
bone marrow, adult	10192-103E3	301.65	27.67
brain, adult, donor1	10084-102B3	192.71	12.30
brain, adult, pool1	10012-101C3	374.94	34.86
brain, fetal, pool1	10085-102B4	96.17	10.69
breast carcinoma cell line:MCF7	10482-107A5	237.20	29.07
breast carcinoma cell line:MDA-MB-453	10419-106C5	410.17	55.42
breast, adult, donor1	10080-102A8	122.48	13.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	389.37	46.75
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	359.31	33.09
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	498.42	75.97
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	105.79	18.64
carcinoid cell line:NCI-H1770	10703-109H1	217.22	18.34
carcinoid cell line:NCI-H727	10735-110B6	227.18	27.13
carcinoid cell line:SK-PN-DW	10719-109I8	491.82	39.93
carcinosarcoma cell line:JHUCS-1	10642-109A3	358.01	25.29
caudate nucleus - adult, donor10196	10177-103C6	417.93	49.51
caudate nucleus, adult, donor10252	10164-103B2	344.86	38.32
caudate nucleus, adult, donor10258	10379-105H1	300.31	38.97
caudate nucleus, newborn, donor10223	10354-105E3	366.23	48.34
cerebellum - adult, donor10196	10173-103C2	381.64	67.01
cerebellum, adult, donor10252	10166-103B4	257.92	74.52
cerebellum, adult, pool1	10083-102B2	249.74	37.94
cerebellum, newborn, donor10223	10357-105E6	429.26	82.20
cerebral meninges, adult	10188-103D8	381.49	35.30
cerebrospinal fluid, donor2	10294-104G6	461.19	74.55
cervical cancer cell line:D98-AH2	10552-107I3	368.37	27.46
cervical cancer cell line:ME-180	10553-107I4	159.09	13.42
cervix, adult, pool1	10013-101C4	337.86	15.01
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	217.09	25.78
chondrosarcoma cell line:SW 1353	10700-109G7	99.28	7.84
choriocarcinoma cell line:BeWo	10423-106C9	269.31	23.24
choriocarcinoma cell line:SCH	10785-110H2	200.71	12.07
choriocarcinoma cell line:T3M-3	10618-108G6	128.55	16.37
chorionic membrane cells, donor1	12238-129G6	157.28	13.11
chorionic membrane cells, donor2	12239-129G7	196.28	23.66
chorionic membrane cells, donor3	12240-129G8	165.94	21.43
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	462.49	73.72
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	977.40	93.55
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	408.65	26.61
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	287.36	58.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	294.37	49.59
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	314.37	43.57
chronic myelogenous leukemia cell line:K562	10454-106G4	326.85	56.83
chronic myelogenous leukemia cell line:KU812	10409-106B4	686.23	28.41
clear cell carcinoma cell line:JHOC-5	10638-108I8	296.01	26.29
clear cell carcinoma cell line:TEN	10636-108I6	255.57	21.86
colon carcinoma cell line:CACO-2	10513-107D9	233.56	29.65
colon carcinoma cell line:COLO-320	10420-106C6	426.45	12.54
colon, adult, donor1	10082-102B1	145.18	14.28
colon, adult, pool1	10014-101C5	307.86	23.62
colon, fetal, donor1	10070-101I7	271.30	15.45
common myeloid progenitor CMP, donor1	12130-128D6	64.17	4.58
common myeloid progenitor CMP, donor2	12134-128E1	400.59	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	243.06	32.72
cord blood derived cell line:COBL-a 24h infection	10453-106G3	277.71	39.09
cord blood derived cell line:COBL-a untreated	10449-106F8	351.82	49.49
corpus callosum, adult, pool1	10042-101F6	219.13	17.91
cruciate ligament, donor2	10295-104G7	199.38	31.61
diaphragm, fetal, donor1	10069-101I6	560.19	65.01
diencephalon, adult	10193-103E4	367.90	41.28
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	318.01	18.14
ductal cell carcinoma cell line:KLM-1	10438-106E6	367.99	41.29
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	147.56	15.41
ductus deferens, adult	10196-103E7	248.67	34.39
duodenum, fetal, donor1, tech_rep1	10071-101I8	191.55	8.64
duodenum, fetal, donor1, tech_rep2	10071-101I8	318.54	13.98
dura mater, adult, donor1	10041-101F5	225.30	11.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	121.70	23.32
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	255.06	44.13
embryonic pancreas cell line:1B2C6	10604-108F1	146.75	12.95
embryonic pancreas cell line:1C3D3	10605-108F2	230.06	15.14
embryonic pancreas cell line:1C3IKEI	10606-108F3	207.17	17.91
embryonic pancreas cell line:2C6	10603-108E9	202.27	17.08
endometrial carcinoma cell line:OMC-2	10497-107C2	261.79	18.77
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	193.38	19.94
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	332.88	44.22
epidermoid carcinoma cell line:A431	10426-106D3	354.15	26.79
epidermoid carcinoma cell line:Ca Ski	10431-106D8	377.36	42.67
epididymis, adult	10197-103E8	283.20	23.86
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	169.60	15.08
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	96.34	9.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	291.06	79.55
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	272.43	58.46
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	278.17	71.14
esophagus, adult, pool1	10015-101C6	299.74	24.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	401.01	9.52
eye - muscle inferior rectus, donor1	10272-104E2	222.14	38.63
eye - muscle lateral, donor2	10298-104H1	359.82	54.71
eye - muscle medial, donor2	10299-104H2	203.89	53.58
eye - muscle superior, donor2	10297-104G9	197.20	41.27
eye - vitreous humor, donor1	10268-104D7	170.51	14.57
eye, fetal, donor1	10054-101G9	379.06	25.42
fibrosarcoma cell line:HT-1080	10758-110E2	195.03	12.95
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	208.45	36.80
frontal lobe, adult, pool1	10040-101F4	446.32	46.82
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	209.27	33.33
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	260.14	17.19
gall bladder, adult	10198-103E9	246.50	12.55
gamma delta positive T cells, donor1	11937-126A2	464.38	20.94
gamma delta positive T cells, donor2	11938-126A3	344.36	20.92
gastric adenocarcinoma cell line:MKN1	10614-108G2	165.17	15.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	174.85	18.76
gastric cancer cell line:AZ521	10549-107H9	285.77	28.86
gastric cancer cell line:GSS	10560-108A2	125.39	12.81
gastrointestinal carcinoma cell line:ECC12	10615-108G3	394.77	32.21
giant cell carcinoma cell line:LU65	10487-107B1	193.22	33.27
giant cell carcinoma cell line:Lu99B	10433-106E1	660.33	36.25
glassy cell carcinoma cell line:HOKUG	10688-109F4	194.55	42.90
glioblastoma cell line:A172, tech_rep1	10444-106F3	139.96	21.43
glioblastoma cell line:A172, tech_rep2	10444-106F3	124.01	24.72
glioblastoma cell line:T98G	10485-107A8	259.16	41.06
glioma cell line:GI-1	10413-106B8	529.52	21.09
globus pallidus - adult, donor10196	10175-103C4	336.03	24.78
globus pallidus, adult, donor10252	10161-103A8	434.98	43.94
globus pallidus, adult, donor10258	10367-105F7	293.01	32.86
globus pallidus, newborn, donor10223	10364-105F4	241.94	20.78
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	109.28	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	277.01	15.68
granulosa cell tumor cell line:KGN	10624-108H3	119.36	8.32
hIPS +CCl2, biol_rep1	14383-156B9	306.69	29.84
hIPS +CCl2, biol_rep2	14384-156C1	194.34	29.72
hIPS +CCl2, biol_rep3	14385-156C2	164.89	30.27
hIPS, biol_rep1	14380-156B6	117.86	43.12
hIPS, biol_rep2	14381-156B7	159.81	37.04
hIPS, biol_rep3	14382-156B8	229.52	39.72
hairy cell leukemia cell line:Mo	10712-109I1	238.21	20.11
heart - mitral valve, adult	10205-103F7	671.78	75.94
heart - pulmonic valve, adult	10206-103F8	848.23	99.10
heart - tricuspid valve, adult	10207-103F9	336.39	51.62
heart, adult, diseased post-infarction, donor1	10050-101G5	324.86	34.89
heart, adult, diseased, donor1	10051-101G6	328.74	60.47
heart, adult, pool1	10016-101C7	714.31	84.63
heart, fetal, pool1	10046-101G1	913.85	49.59
hepatic mesenchymal tumor cell line:LI90	10778-110G4	243.43	9.56
hepatoblastoma cell line:HuH-6	10633-108I3	298.48	19.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	179.22	36.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	200.63	37.63
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	189.27	36.78
hepatoma cell line:Li-7	10484-107A7	311.85	44.49
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	350.85	27.94
hippocampus - adult, donor10196	10169-103B7	337.84	42.58
hippocampus, adult, donor10252	10153-102I9	353.09	41.43
hippocampus, adult, donor10258	10374-105G5	143.41	31.87
hippocampus, newborn, donor10223	10363-105F3	135.00	23.26
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	953.97	115.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	268.81	39.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	412.33	50.53
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	294.34	12.97
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	385.51	25.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	417.19	31.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	270.64	21.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	220.17	17.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	193.94	16.27
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	290.07	31.02
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	256.34	26.36
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	281.44	24.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	249.75	28.17
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	324.25	37.34
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	793.33	108.22
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	313.86	17.37
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	225.89	14.39
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	842.60	51.48
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	202.33	9.04
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	249.64	11.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	282.23	15.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	205.43	26.62
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	172.44	12.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	240.63	19.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	296.33	41.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	239.35	32.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	623.49	84.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	274.27	21.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	201.45	19.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	266.31	20.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	178.41	14.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	185.97	15.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	220.36	19.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	193.27	20.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	180.98	21.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	239.27	27.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	248.03	34.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	613.67	92.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	367.81	33.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	216.07	17.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4434.17	315.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	531.82	38.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	188.82	10.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	233.42	14.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	230.25	19.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	119.34	22.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	256.90	20.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	240.30	29.09
immature langerhans cells, donor1	11904-125F5	287.43	18.65
immature langerhans cells, donor2	11905-125F6	144.96	11.88
insula, adult, pool1	10039-101F3	288.63	27.82
keratoacanthoma cell line:HKA-1	10791-110H8	193.14	14.96
kidney, adult, pool1	10017-101C8	377.88	61.48
kidney, fetal, pool1	10045-101F9	123.36	9.90
large cell lung carcinoma cell line:IA-LM	10509-107D5	314.01	11.36
large cell lung carcinoma cell line:NCI-H460	10839-111E2	215.93	10.37
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	169.00	15.78
left atrium, adult, donor1	10079-102A7	855.42	91.53
left ventricle, adult, donor1	10078-102A6	716.01	90.01
leiomyoblastoma cell line:G-402	10721-110A1	185.78	16.42
leiomyoma cell line:10964C	10569-108B2	154.48	20.84
leiomyoma cell line:15242A	10570-108B3	169.57	21.20
leiomyoma cell line:15425	10571-108B4	184.05	30.35
leiomyosarcoma cell line:Hs 5.T	10722-110A2	139.69	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	185.06	28.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	419.81	20.42
liposarcoma cell line:KMLS-1	10782-110G8	230.88	9.69
liposarcoma cell line:SW 872	10726-110A6	176.30	18.89
liver, adult, pool1	10018-101C9	228.34	31.60
liver, fetal, pool1	10086-102B5	79.02	8.47
locus coeruleus - adult, donor10196	10182-103D2	316.29	52.06
locus coeruleus, adult, donor10252	10165-103B3	361.72	52.23
locus coeruleus, adult, donor10258	10375-105G6	154.05	23.14
locus coeruleus, newborn, donor10223	10362-105F2	416.83	37.01
lung adenocarcinoma cell line:A549	10499-107C4	282.60	22.97
lung adenocarcinoma cell line:PC-14	10408-106B3	210.27	43.43
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	111.38	10.81
lung, adult, pool1	10019-101D1	236.02	12.40
lung, fetal, donor1	10068-101I5	323.37	12.27
lung, right lower lobe, adult, donor1	10075-102A3	173.66	11.00
lymph node, adult, donor1	10077-102A5	160.00	9.47
lymphangiectasia cell line:DS-1	10727-110A7	266.96	16.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	418.82	35.47
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	239.56	33.13
mature adipocyte, donor1	12231-129F8	222.44	28.42
mature adipocyte, donor2	12232-129F9	267.09	27.19
mature adipocyte, donor3	12233-129G1	244.41	33.19
mature adipocyte, donor4	12234-129G2	466.68	43.43
maxillary sinus tumor cell line:HSQ-89	10414-106B9	349.53	24.78
medial frontal gyrus - adult, donor10196	10170-103B8	408.35	75.58
medial frontal gyrus, adult, donor10252	10150-102I6	352.36	65.84
medial frontal gyrus, adult, donor10258	10368-105F8	559.13	75.61
medial frontal gyrus, newborn, donor10223	10352-105E1	823.97	98.52
medial temporal gyrus - adult, donor10196	10183-103D3	546.42	70.88
medial temporal gyrus, adult, donor10252	10156-103A3	330.86	59.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	235.00	21.19
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2181.75	229.66
medial temporal gyrus, newborn, donor10223	10353-105E2	232.23	25.13
medulla oblongata - adult, donor10196	10174-103C3	389.39	53.87
medulla oblongata, adult, donor10252	10155-103A2	347.53	52.32
medulla oblongata, adult, pool1	10038-101F2	209.86	24.65
medulla oblongata, newborn, donor10223	10361-105F1	198.24	27.08
medulloblastoma cell line:D283 Med	10838-111E1	874.58	39.19
medulloblastoma cell line:ONS-76	10759-110E3	245.03	30.45
melanoma cell line:COLO 679	10514-107E1	264.64	34.64
melanoma cell line:G-361	10465-106H6	273.09	17.92
meningioma cell line:HKBMM	10691-109F7	165.35	16.64
merkel cell carcinoma cell line:MKL-1	10843-111E6	344.53	44.94
merkel cell carcinoma cell line:MS-1	10844-111E7	263.63	40.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	237.98	35.75
mesenchymal precursor cell - adipose, donor2	11748-123G2	232.13	14.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	127.13	26.09
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	245.41	28.94
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	247.45	20.41
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	139.51	15.96
mesenchymal precursor cell - cardiac, donor1	11752-123G6	203.56	12.70
mesenchymal precursor cell - cardiac, donor2	11753-123G7	133.65	15.18
mesenchymal precursor cell - cardiac, donor3	11754-123G8	215.00	39.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	209.85	33.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	168.15	27.03
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	151.50	11.53
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	195.52	28.09
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	171.75	26.53
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	202.12	24.70
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	109.63	11.86
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	154.76	14.28
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	92.56	13.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	177.47	39.02
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	176.19	23.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	184.25	25.47
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	195.12	8.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	110.46	10.02
mesenchymal stem cell line:Hu5/E18	10568-108B1	244.19	38.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	212.35	16.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	303.62	19.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	221.18	16.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	202.10	18.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	284.07	20.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	249.10	25.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	214.56	15.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	282.20	19.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	821.16	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	360.81	26.25
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	227.34	19.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	254.29	21.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	365.93	22.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	248.05	20.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	264.87	20.06
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	278.35	21.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	216.02	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	227.26	15.49
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	233.52	19.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	253.17	14.55
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	221.23	15.46
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	198.72	16.36
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	181.92	15.16
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	167.90	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	216.58	16.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	209.76	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	203.39	17.79
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	276.59	14.62
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	243.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	262.85	18.37
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	204.53	11.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	277.25	23.64
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	219.55	19.96
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	313.39	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	288.90	13.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	351.94	11.92
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	292.99	10.61
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	292.38	9.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	323.47	8.02
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	294.49	24.84
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	315.86	43.66
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	275.36	19.96
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	422.07	51.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	411.59	34.77
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	454.15	49.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	297.00	38.69
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	318.37	39.25
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	233.14	32.94
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	288.88	29.74
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	402.19	36.15
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	341.83	34.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	385.54	37.70
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	306.32	24.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	314.76	30.56
mesodermal tumor cell line:HIRS-BM	10696-109G3	164.03	12.38
mesothelioma cell line:ACC-MESO-1	10493-107B7	231.04	30.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	161.94	32.43
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	183.76	25.64
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	278.25	33.19
mesothelioma cell line:Mero-25	10850-111F4	65.59	4.77
mesothelioma cell line:Mero-41	10851-111F5	155.49	21.02
mesothelioma cell line:Mero-48a	10852-111F6	155.67	23.25
mesothelioma cell line:Mero-82	10853-111F7	251.77	18.66
mesothelioma cell line:Mero-83	10854-111F8	196.09	23.32
mesothelioma cell line:Mero-84	10855-111F9	93.53	5.06
mesothelioma cell line:Mero-95	10856-111G1	194.00	15.53
mesothelioma cell line:NCI-H2052	10847-111F1	164.49	19.05
mesothelioma cell line:NCI-H226	10846-111E9	217.73	20.81
mesothelioma cell line:NCI-H2452	10848-111F2	146.57	19.99
mesothelioma cell line:NCI-H28	10845-111E8	314.77	37.66
mesothelioma cell line:No36	10857-111G2	169.30	26.10
mesothelioma cell line:ONE58	10858-111G3	74.24	14.09
migratory langerhans cells, donor1	11901-125F2	210.16	16.89
migratory langerhans cells, donor2	11902-125F3	84.26	8.55
migratory langerhans cells, donor3	11903-125F4	378.17	19.02
mixed mullerian tumor cell line:HTMMT	10689-109F5	289.91	43.42
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	204.52	16.74
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	143.05	6.22
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	232.73	25.31
myelodysplastic syndrome cell line:SKM-1	10772-110F7	798.12	65.42
myeloma cell line:PCM6	10474-106I6	264.48	20.16
myxofibrosarcoma cell line:MFH-ino	10600-108E6	161.83	16.23
myxofibrosarcoma cell line:NMFH-1	10684-109E9	199.47	25.69
nasal epithelial cells, donor1, tech_rep1	12226-129F3	177.83	13.48
nasal epithelial cells, donor1, tech_rep2	12226-129F3	246.58	21.11
nasal epithelial cells, donor2	12227-129F4	140.76	6.62
neuroblastoma cell line:CHP-134	10508-107D4	406.06	14.95
neuroblastoma cell line:NB-1	10539-107G8	377.91	30.49
neuroblastoma cell line:NBsusSR	10607-108F4	254.33	22.99
neuroblastoma cell line:NH-12	10555-107I6	318.47	12.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	365.56	11.86
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	393.26	26.13
neuroectodermal tumor cell line:TASK1	10774-110F9	332.28	7.65
neuroepithelioma cell line:SK-N-MC	10728-110A8	325.51	20.98
neurofibroma cell line:Hs 53.T	10729-110A9	147.19	16.24
neutrophil PMN, donor1	12133-128D9	14.87	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28
neutrophil PMN, donor3	12141-128E8	75.77	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	390.33	17.76
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1124.71	362.63
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	312.27	12.18
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	174.21	26.54
nucleus accumbens, adult, pool1	10037-101F1	337.46	31.03
occipital cortex - adult, donor10196	10172-103C1	513.04	84.48
occipital cortex, adult, donor10252	10163-103B1	318.28	47.50
occipital cortex, newborn, donor10223	10355-105E4	220.91	38.58
occipital lobe, adult, donor1	10076-102A4	343.22	47.49
occipital lobe, fetal, donor1	10073-102A1	214.55	18.45
occipital pole, adult, pool1	10036-101E9	102.34	12.54
olfactory region, adult	10195-103E6	301.10	38.02
optic nerve, donor1	10277-104E7	298.16	16.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	188.06	22.33
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	338.11	21.43
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	293.78	32.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	251.46	11.09
osteoclastoma cell line:Hs 706.T	10704-109H2	124.94	8.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	435.40	31.77
osteosarcoma cell line:HS-Os-1	10558-107I9	564.71	36.47
ovary, adult, pool1	10020-101D2	332.72	8.65
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	132.36	11.55
pancreas, adult, donor1	10049-101G4	270.90	18.81
pancreatic carcinoma cell line:NOR-P1	10698-109G5	165.48	19.01
papillary adenocarcinoma cell line:8505C	10437-106E5	250.08	43.27
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	251.02	11.76
paracentral gyrus, adult, pool1	10035-101E8	282.99	39.08
parietal cortex, adult, donor10258	10373-105G4	289.20	38.90
parietal lobe - adult, donor10196	10171-103B9	337.63	57.37
parietal lobe, adult, donor10252	10157-103A4	366.56	70.69
parietal lobe, adult, pool1	10034-101E7	236.78	34.28
parietal lobe, fetal, donor1	10072-101I9	253.13	18.43
parietal lobe, newborn, donor10223	10356-105E5	244.88	31.03
parotid gland, adult	10199-103F1	384.18	29.60
penis, adult	10200-103F2	423.24	44.58
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	288.20	20.08
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	254.53	31.32
pineal gland - adult, donor10196	10179-103C8	309.61	25.16
pineal gland, adult, donor10252	10160-103A7	560.83	53.30
pineal gland, adult, donor10258	10377-105G8	233.90	39.51
pituitary gland - adult, donor10196	10180-103C9	735.58	44.52
pituitary gland, adult, donor10252	10162-103A9	781.77	61.50
pituitary gland, adult, donor10258	10378-105G9	348.16	42.56
placenta, adult, pool1	10021-101D3	141.90	10.54
plasma cell leukemia cell line:ARH-77	10840-111E3	345.10	28.07
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	173.54	11.21
pons, adult, pool1	10033-101E6	371.12	52.76
postcentral gyrus, adult, pool1	10032-101E5	219.59	27.55
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	297.43	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	11.74
prostate cancer cell line:DU145	10490-107B4	275.59	37.29
prostate cancer cell line:PC-3	10439-106E7	631.63	107.27
prostate, adult, pool1	10022-101D4	325.31	11.88
putamen, adult, donor10196	10176-103C5	582.37	64.68
putamen, adult, donor10252	10152-102I8	527.43	90.19
putamen, adult, donor10258, tech_rep1	10372-105G3	191.24	38.25
putamen, adult, donor10258, tech_rep2	10372-105G3	308.06	36.48
putamen, newborn, donor10223	10365-105F5	668.70	73.47
rectal cancer cell line:TT1TKB	10469-106I1	217.91	18.04
rectum, fetal, donor1	10067-101I4	254.55	15.30
renal cell carcinoma cell line:OS-RC-2	10411-106B6	139.49	15.69
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	141.25	11.60
retina, adult, pool1	10030-101E3	218.08	15.11
retinoblastoma cell line:Y79	10475-106I7	431.27	16.89
rhabdomyosarcoma cell line:KYM-1	10787-110H4	234.83	13.77
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	683.88	25.87
sacrococcigeal teratoma cell line:HTST	10695-109G2	261.46	11.37
salivary acinar cells, donor1	11771-123I7	262.21	10.84
salivary acinar cells, donor2	11772-123I8	219.89	12.80
salivary acinar cells, donor3	11773-123I9	100.63	7.94
salivary gland, adult, pool1	10093-102C3	204.76	36.03
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	181.27	11.04
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	181.26	13.05
seminal vesicle, adult	10201-103F3	286.76	26.45
serous adenocarcinoma cell line:JHOS-2	10639-108I9	167.13	26.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	138.90	19.63
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	153.54	39.14
serous cystadenocarcinoma cell line:HTOA	10693-109F9	140.10	10.34
signet ring carcinoma cell line:Kato III	10436-106E4	240.62	40.34
signet ring carcinoma cell line:NUGC-4	10483-107A6	182.05	37.29
skeletal muscle - soleus muscle, donor1	10282-104F3	798.00	148.96
skeletal muscle, adult, pool1	10023-101D5	565.38	51.09
skeletal muscle, fetal, donor1	10066-101I3	253.26	9.05
skin, adult, donor1	10074-102A2	142.49	13.57
skin, fetal, donor1	10065-101I2	320.66	27.14
small cell cervical cancer cell line:HCSC-1	10800-110I8	289.50	60.70
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	804.09	52.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	424.62	53.97
small cell lung carcinoma cell line:LK-2	10541-107H1	565.19	60.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	357.41	20.27
small cell lung carcinoma cell line:WA-hT	10562-108A4	184.79	91.96
small intestine, adult, pool1	10024-101D6	325.36	42.40
small intestine, fetal, donor1	10064-101I1	162.65	9.83
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	205.16	40.52
smooth muscle, adult, pool1	10048-101G3	443.51	14.47
somatostatinoma cell line:QGP-1	10781-110G7	157.06	19.03
spinal cord - adult, donor10196	10181-103D1	390.68	36.48
spinal cord, adult, donor10252	10159-103A6	423.84	32.72
spinal cord, adult, donor10258	10369-105F9	410.24	40.82
spinal cord, fetal, donor1	10056-101H2	323.21	30.49
spinal cord, newborn, donor10223	10359-105E8	570.80	57.40
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	137.26	10.60
spleen, adult, pool1	10025-101D7	226.99	13.66
spleen, fetal, pool1	10044-101F8	83.27	5.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	323.79	30.64
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	270.00	18.42
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	479.45	42.28
squamous cell carcinoma cell line:T3M-5	10616-108G4	183.35	8.99
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	352.76	46.15
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	181.73	32.62
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	85.88	19.46
stomach, fetal, donor1	10062-101H8	409.03	11.75
submaxillary gland, adult	10202-103F4	388.52	33.04
substantia nigra - adult, donor10196	10178-103C7	1248.31	54.27
substantia nigra, adult, donor10252	10158-103A5	337.11	35.52
substantia nigra, adult, donor10258	10371-105G2	218.80	50.17
substantia nigra, newborn, donor10223	10358-105E7	221.16	19.08
synovial sarcoma cell line:HS-SY-II	10441-106E9	294.84	52.50
temporal lobe, adult, pool1	10031-101E4	122.24	15.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	300.58	20.66
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	225.04	16.70
tenocyte, donor1	11763-123H8	198.64	17.11
tenocyte, donor2	11765-123I1	201.82	11.45
tenocyte, donor3	11768-123I4	202.01	24.46
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	281.11	30.25
teratocarcinoma cell line:NCR-G1	10798-110I6	188.99	12.49
teratocarcinoma cell line:PA-1	10807-111A6	352.88	14.57
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	622.30	69.44
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	160.35	19.29
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	345.40	33.59
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	269.36	41.69
testis, adult, pool1	10026-101D8	219.79	21.15
testis, adult, pool2	10096-102C6	87.51	33.38
thalamus - adult, donor10196	10168-103B6	400.75	29.81
thalamus, adult, donor10252	10154-103A1	339.92	40.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	221.70	66.20
thalamus, adult, donor10258, tech_rep2	10370-105G1	133.23	27.01
thalamus, newborn, donor10223	10366-105F6	285.93	49.48
throat, adult	10209-103G2	546.28	53.43
throat, fetal, donor1	10061-101H7	386.37	26.81
thymic carcinoma cell line:Ty-82	10803-111A2	275.84	20.27
thymus, adult, pool1	10027-101D9	214.94	15.31
thymus, fetal, pool1	10043-101F7	336.13	17.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	516.42	69.80
thyroid carcinoma cell line:TCO-1	10783-110G9	305.64	19.28
thyroid, adult, pool1	10028-101E1	321.18	25.38
thyroid, fetal, donor1	10060-101H6	211.46	28.21
tongue epidermis (fungiform papillae), donor1	10288-104F9	144.74	18.48
tongue, adult	10203-103F5	632.84	89.31
tongue, fetal, donor1	10059-101H5	739.71	87.88
tonsil, adult, pool1	10047-101G2	165.39	15.73
trachea, adult, pool1	10029-101E2	214.80	17.67
trachea, fetal, donor1	10058-101H4	278.90	20.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	207.25	26.57
transitional-cell carcinoma cell line:5637	10418-106C4	269.30	28.98
transitional-cell carcinoma cell line:JMSU1	10492-107B6	293.79	17.39
tridermal teratoma cell line:HGRT	10694-109G1	176.94	13.32
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	247.26	13.97
umbilical cord, fetal, donor1	10057-101H3	242.03	31.30
uterus, adult, pool1	10100-102D1	137.01	10.92
uterus, fetal, donor1	10055-101H1	311.25	13.31
vagina, adult	10204-103F6	267.53	6.46
vein, adult	10191-103E2	227.97	13.15
xeroderma pigentosum b cell line:XPL 17	10563-108A5	225.38	12.02